NeoGenesis NMN-H (UthPeak®) Capsules

Supports healthy cellular NAD+ (Nicotinamide Adenine Dinucleotide) levels, mitochondrial function, energy metabolism, and healthy aging processes. A next-generation NAD+ precursor designed for superior bioavailability and more efficient NAD+ elevation compared to standard NMN (Nicotinamide Mononucleotide).

NAD+ is a critical coenzyme found in all living cells that is essential for cellular energy production, DNA repair, sirtuin activation, and metabolic regulation.

NMN-H (Reduced Nicotinamide Mononucleotide / NMNH) is the reduced form of NMN. While standard NMN is an oxidised molecule, NMN-H carries an additional hydrogen atom, enabling it to be processed through a unique enzymatic pathway. Preclinical and clinical research on UthPeak® NMNH indicates it can raise NAD+ levels more rapidly and substantially than conventional NMN, while also supporting NADH balance, which plays a key role in cellular ATP (Adenosine Triphosphate) or energy production.

By boosting intracellular NAD+, NMN-H supports sirtuin activation, mitochondrial efficiency, DNA repair, cellular resilience, and overall vitality. It is ideal for individuals seeking advanced anti-aging support, sustained energy, and healthy cellular aging.

NMN-H can be used in combination with a β-NAD+ Nasal Spray or Pen and other NAD+ precursor products such as a Nicotinamide Riboside (NR) Nasal Spray or IV drip for synergistic NAD+ pathway support and enhanced longevity benefits. Book a consultation with one of our independent, HPCSA-registered medical practitioners to enquire about a NAD+ optimization program.

Strength: 250 mg UthPeak® NMNH per capsule (30 servings)

Volume: 30 capsules

Dosage Form: Capsules